TSMHT
ROIV icon

Thurston Springer Miller Herd & Titak’s Roivant Sciences ROIV Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Hold
455
– – 0.01% 734
2026
Q1 		$12.6K Hold
455
– – 0.01% 868
2025
Q4 		$9.87K Buy
+455
New +$8.98K ﹤0.01% 954
2025
Q3 		– Sell
-455
Closed -$5.13K – 1194
2025
Q2 		$5.13K Hold
455
– – ﹤0.01% 1277
2025
Q1 		$4.59K Buy
+455
New +$4.92K ﹤0.01% 1295
2024
Q3 		– Sell
-200
Closed -$2.11K – 1565
2024
Q2 		$2.11K Buy
+200
New +$2.19K ﹤0.01% 1298

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's ROIV Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Roivant Sciences (ROIV) position steady in Q2 2026 at 455 shares worth $16.1K. The position accounts for 0.01% of the portfolio, ranked #734.

Thurston Springer Miller Herd & Titak first reported a position in ROIV in Q2 2024 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 455 shares of Roivant Sciences worth $16.1K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up 0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #734 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Roivant Sciences in Q2 2024 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.